- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VIR
Recent news which mentions VIR
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
From Benzinga
GFAI Stock: The Thailand Deal That Has Guardforce AI Investors Saying Cha-Ching Today
November 30, 2021
From InvestorPlace
From MarketWatch
VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.
November 30, 2021
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 30, 2021
From Benzinga
From InvestorPlace
50 Biggest Movers From Yesterday
November 30, 2021
From Benzinga
From Benzinga
33 Stocks Moving In Monday's Mid-Day Session
November 29, 2021
From Benzinga
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
From Benzinga
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 26, 2021
From Benzinga
Europe is the only region where COVID-19 deaths rose in the latest week, and U.S. to greatly expand vaccine manufacturing
November 17, 2021
From MarketWatch
US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B
November 17, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 17, 2021
From Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
From Benzinga
From InvestorPlace
This Treasury dealer says the market has it entirely wrong on the Fed and interest rates. Here’s why.
November 17, 2021
From MarketWatch
25 Stocks Moving in Wednesday's Pre-Market Session
November 17, 2021
From Benzinga
From MarketWatch
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
November 12, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.